Bausch Health Companies (BHC) Payables (2009 - 2026)
Bausch Health Companies (BHC) reported Payables of $593.0 million for Q1 2026, down 4.35% on a YoY basis from $620.0 million in Q1 2025, and down 1.17% sequentially from $600.0 million in Q4 2025.
Bausch Health Companies (BHC) Payables (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Payables data on file, last reported at $593.0 million in Q1 2026.
- For the quarter ending Q1 2026, Payables fell 4.35% year-over-year to $593.0 million; the trailing twelve-month figure through Mar 2026 stood at $593.0 million (down 4.35% YoY), and the FY2025 full-year result was $600.0 million, up 1.87% from the prior year.
- Payables retreated to $593.0 million in Q1 2026, from $600.0 million in the prior quarter.
- In the past five years, Payables ranged from a high of $719.0 million in Q4 2023 to a low of $471.0 million in Q1 2022.
- A 5-year average of $583.0 million and a median of $589.0 million in 2024 frame the typical range for Payables.
- Across the five-year window, Payables soared 38.0% in 2023 and slipped 18.08% in 2024, its largest moves.
- Tracing BHC's Payables over 5 years: stood at $521.0 million in 2022, then jumped by 38.0% to $719.0 million in 2023, then retreated by 18.08% to $589.0 million in 2024, then gained by 1.87% to $600.0 million in 2025, then dropped by 1.17% to $593.0 million in 2026.
- Business Quant data shows BHC's Payables at $593.0 million in Q1 2026, $600.0 million in Q4 2025, and $616.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 731.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 8.82 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | 593.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 593.00 Mn |
| Dec 31, 2025 | 600.00 Mn |
| Sep 30, 2025 | 616.00 Mn |
| Jun 30, 2025 | 627.00 Mn |
| Mar 31, 2025 | 620.00 Mn |
| Dec 31, 2024 | 589.00 Mn |
| Sep 30, 2024 | 667.00 Mn |
| Jun 30, 2024 | 579.00 Mn |
| Mar 31, 2024 | 642.00 Mn |
| Dec 31, 2023 | 719.00 Mn |
| Sep 30, 2023 | 569.00 Mn |
| Jun 30, 2023 | 515.00 Mn |
| Mar 31, 2023 | 561.00 Mn |
| Dec 31, 2022 | 521.00 Mn |
| Sep 30, 2022 | 486.00 Mn |
| Jun 30, 2022 | 536.00 Mn |
| Mar 31, 2022 | 471.00 Mn |
| Dec 31, 2021 | 407.00 Mn |
| Sep 30, 2021 | 455.00 Mn |
| Jun 30, 2021 | 442.00 Mn |